MX2007011665A - Terapeutico para influenza. - Google Patents

Terapeutico para influenza.

Info

Publication number
MX2007011665A
MX2007011665A MX2007011665A MX2007011665A MX2007011665A MX 2007011665 A MX2007011665 A MX 2007011665A MX 2007011665 A MX2007011665 A MX 2007011665A MX 2007011665 A MX2007011665 A MX 2007011665A MX 2007011665 A MX2007011665 A MX 2007011665A
Authority
MX
Mexico
Prior art keywords
rnai
influenza
inducing
influenza virus
provides
Prior art date
Application number
MX2007011665A
Other languages
English (en)
Spanish (es)
Inventor
Jianzhu Chen
Herman N Eisen
Qing Ge
Original Assignee
Massachusetts Inst Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/102,097 external-priority patent/US20060160759A1/en
Application filed by Massachusetts Inst Technology filed Critical Massachusetts Inst Technology
Publication of MX2007011665A publication Critical patent/MX2007011665A/es

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX2007011665A 2005-03-22 2006-03-22 Terapeutico para influenza. MX2007011665A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US66458005P 2005-03-22 2005-03-22
US11/102,097 US20060160759A1 (en) 2002-09-28 2005-04-08 Influenza therapeutic
PCT/US2006/010491 WO2006102461A2 (en) 2005-03-22 2006-03-22 Influenza therapeutic

Publications (1)

Publication Number Publication Date
MX2007011665A true MX2007011665A (es) 2007-11-14

Family

ID=39406020

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2007011665A MX2007011665A (es) 2005-03-22 2006-03-22 Terapeutico para influenza.

Country Status (5)

Country Link
JP (1) JP2008533990A (ro)
CN (1) CN101180395A (ro)
IL (1) IL186057A0 (ro)
MX (1) MX2007011665A (ro)
NO (1) NO20074929L (ro)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103966212A (zh) * 2013-02-06 2014-08-06 霍晋 A型流感病毒NP基因有干扰作用的siRNA序列的设计及应用
CN103966213A (zh) * 2013-02-06 2014-08-06 霍晋 A型流感病毒M基因有干扰作用的siRNA序列的设计和干扰作用的鉴定
CN103966214A (zh) * 2013-02-06 2014-08-06 霍晋 A型流感病毒PB基因有干扰作用的siRNA序列的设计及应用
RU2716420C2 (ru) * 2013-06-17 2020-03-11 Те Брод Инститьют Инк. Доставка и применение систем crispr-cas, векторов и композиций для целенаправленного воздействия и терапии в печени
ES2796930T3 (es) * 2014-01-23 2020-11-30 Univ Colorado State Res Found Silenciamiento de ARNip mediado por E. coli de la gripe aviar en pollos
CN106381296A (zh) * 2015-11-19 2017-02-08 中国农业科学院哈尔滨兽医研究所 表达多基因抗流感转基因动物的构建方法
CN106947763B (zh) * 2017-03-20 2019-11-12 中国医学科学院医药生物技术研究所 可雾化吸入的抗流感病毒感染的siRNA及其应用
WO2020160511A1 (en) 2019-02-01 2020-08-06 The Board Of Trustees Of The Leland Stanford Junior University Immolative cell-penetrating complexes for nucleic acid delivery to the lung
EP3996686A4 (en) * 2019-07-10 2023-06-28 The University of Hong Kong Pegylated synthetic kl4 peptide, compositions and methods thereof

Also Published As

Publication number Publication date
CN101180395A (zh) 2008-05-14
JP2008533990A (ja) 2008-08-28
NO20074929L (no) 2007-12-18
IL186057A0 (en) 2008-01-20

Similar Documents

Publication Publication Date Title
WO2006102461A3 (en) Influenza therapeutic
MX2007011665A (es) Terapeutico para influenza.
Chiang et al. Sequence-specific modifications enhance the broad-spectrum antiviral response activated by RIG-I agonists
MX2023010958A (es) Agentes de arn modificados con efecto reducido fuera de la diana.
Zhang et al. Induction of the cellular miR-29c by influenza virus inhibits the innate immune response through protection of A20 mRNA
Selvamani et al. Chikungunya virus exploits miR-146a to regulate NF-κB pathway in human synovial fibroblasts
MX2024005652A (es) Agentes de acido ribonucleico (arn) de cadena doble modificados.
MX359548B (es) Agentes de iarn modificados.
Huang et al. Eriocheir sinensis microRNA-7 targets crab Myd88 to enhance white spot syndrome virus replication
WO2015106128A3 (en) Rnai agents modified at the 4'-c-position
JP2010505897A (ja) インフルエンザターゲット
JP2019508045A (ja) がんを処置するための組み合わせベクターおよび方法
US20110184045A1 (en) Silencng and rig-i activation by dual function oligonucleotides
BR112019009953A2 (pt) substâncias direcionadas a vários órgãos ou tecidos selecionados
WO2019217397A3 (en) Compositions and methods for improving strand biased
US20200345756A1 (en) Compositions and methods for treating age-related macular degeneration and geographic atrophy
Lozić et al. Overexpression of oxytocin receptors in the hypothalamic PVN increases baroreceptor reflex sensitivity and buffers BP variability in conscious rats
He et al. MicroRNA-182-3p negatively regulates cytokines expression by targeting TLR5M in orange-spotted grouper, Epinephelus coioides
KR101638156B1 (ko) C형 간염 바이러스 감염 질환의 예방 또는 치료용 약학 조성물
JP2024500036A (ja) 抱合体
JP4054844B2 (ja) 副作用のないＲＮＡｉ医薬
MX2023008469A (es) Oligonucleotidos de doble hebra modificados.
RU2013121802A (ru) Профилактический или терапевтический агент для лечения фиброза
Talari et al. MicroRNA-712 restrains macrophage pro-inflammatory responses by targeting LRRK2 leading to restoration of insulin stimulated glucose uptake by myoblasts
Liu et al. ASF1a enhances antiviral immune response by associating with CBP to mediate acetylation of H3K56 at the Ifnb promoter

Legal Events

Date Code Title Description
FA Abandonment or withdrawal